As the demographics of the population changes, increasing challenges are being faced in providing reliable access for dialysis. This article reports on the outcomes from the largest series to date using the early cannulation graft Flixene in a single centre.
Methods:
Between May 2012 and March 2018, 141 Flixene grafts were placed for dialysis access. The outcomes of the arteriovenous grafts were reviewed retrospectively from electronically held records and imaging.
Results:
In 75 patients, placement of Flixene graft was performed on an emergency basis and in 66 patients on a planned elective list. The 12-month primary, assisted primary and secondary patency rates were 48.7%, 56.6% and 83.6%, respectively. Eight (5.7%) patients developed infections of the graft during the follow-up period.
Conclusion:
In our experience, we have found the use of the early cannulation graft Flixene to be safe with a low complication rate and favourable patency rates. We believe these early cannulation grafts provide a useful addition for vascular access surgeons preventing the use of tunnelled lines and providing more flexibility in the timing of placing a graft for dialysis.
End Stage Renal Disease (ESRD) National Coordinating Center (NCC). Fistula first catheter last (FFCL), http://esrdncc.org/ffcl/ (accessed 15 May 2019).
2.
BesarabA.Resolved: fistulas are preferred to grafts as initial vascular access for dialysis. J Am Soc Nephrol2008; 19(9): 1629–1631.
3.
VassalottiJAJenningsWCBeathardGA, et al. Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial2012; 25(3): 303–310.
4.
SidawyANSpergelLMBesarabA, et al. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. Journal of Vascular Surgery2008; 48(5Suppl.): 2S–25S.
5.
UdayarajUPHaynesRWinearlsCG.Late presentation of patients with end-stage renal disease for renal replacement therapy – is it always avoidable?Nephrol Dial Transplant2011; 26(11): 3646–3651.
6.
KerrM.Chronic Kidney Disease in England: the human and financial cost: report for NHS Kidney Care. London: Insight Health Economics, 2012.
7.
HoggardJSaadTSchonD, et al. Guidelines for venous access in patients with chronic kidney disease. A Position Statement from the American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee and the Association for Vascular Access. Semin Dial2008; 21(2): 186–191.
8.
AllenAWMegargellJLBrownDB, et al. Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol2000; 11(10): 1309–1314.
9.
GonsalvesCFEschelmanDJSullivanKL, et al. Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement. Cardiovasc Intervent Radiol2003; 26(2): 123–127.
10.
Al ShakarchiJInstonN. Timing of cannulation of arteriovenous grafts: are we too cautious?Clin Kidney J2015; 8(3): 290–292.
11.
LeeTMokrzyckiMMoistL, et al. Standardized definitions for hemodialysis vascular access. Semin Dial2011; 24(5): 515–524.
12.
SidawyANGrayRBesarabA, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg2002; 35(3): 603–610.
13.
Al-JaishiAAOliverMJThomasSM, et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis2014; 63(3): 464–478.
14.
LokCEOliverMJSuJ, et al. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int2005; 67(6): 2462–2469.
15.
LeeTBarkerJAllonM.Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol2007; 18(6): 1936–1941.
16.
WagnerJKDillavouENagU, et al. Immediate-access grafts provide comparable patency to standard grafts, with fewer reinterventions and catheter-related complications. J Vasc Surg2019; 69(3): 883–889.
17.
GomesASchmidtRWishJ.Re-envisioning Fistula First in a patient-centered culture. Clin J Am Soc Nephrol2013; 8(10): 1791–1797.
18.
BylsmaLCGageSMReichertH, et al. Arteriovenous fistulae for haemodialysis: a systematic review and meta-analysis of efficacy and safety outcomes. Eur J Vasc Endovasc Surg2017; 54(4): 513–522.
19.
LioupisCMistryHRixT, et al. Comparison among transposed brachiobasilic, brachiobrachial arteriovenous fistulas and Flixene vascular graft. J Vasc Access2011; 12(1): 36–44.
20.
SchildAFSchumanESNoicelyK, et al. Early cannulation prosthetic graft (Flixene) for arteriovenous access. J Vasc Access2011; 12(3): 248–252.
21.
ChemlaESNelsonSMorsyM.Early cannulation grafts in straight axillo-axillary angioaccesses avoid central catheter insertions. Semin Dial2011; 24(4): 456–459.
22.
ScarrittTParagoneCMO’GormanRB, et al. Traditional versus early-access grafts for hemodialysis access: a single-institution comparative study. Am Surg2014; 80(2): 155–158.
23.
ChiangNHulmeKRHaggartPC, et al. Comparison of FLIXENE and standard PTFE arteriovenous graft for early haemodialysis. J Vasc Access2014; 15(2): 116–122.
24.
BerardXOttavianiNBrizziV, et al. Use of the Flixene vascular access graft as an early cannulation solution. J Vasc Surg2015; 62(1): 128–134.
25.
HinojosaCASoto-SolisSOlivares-CruzS, et al. Early cannulation graft Flixene for conventional and complex hemodialysis access creation. J Vasc Access2017; 18(2): 109–113.
26.
GlickmanMHBurgessJCullD, et al. Prospective multicenter study with a 1-year analysis of a new vascular graft used for early cannulation in patients undergoing hemodialysis. J Vasc Surg2015; 62(2): 434–441.
27.
SchildAFBaltodanoNMAlfieriK, et al. New graft for low friction tunneling in vascular access surgery. J Vasc Access2004; 5(1): 19–24.
28.
TrautmannMWiedeckHRuhnkeM, et al. Teicoplanin: 10 years of clinical experience. Infection1994; 22(6): 430–436.
